−780KRW
−20.71 BKRW
162.67 BKRW
11.86 M
About KDPHARM
Sector
CEO
Gi-Sung Ryu
Headquarters
Hwaseong-si
Website
Employees (FY)
405
Founded
1976
ISIN
KR7011040003
FIGI
BBG000C1BXN3
KYUNG DONG PHARMACEUTICAL Co., Ltd. engages in the manufacture and sale of medicines for liver therapy, gastrointestinal, antimigrain, osteoporosis, cardiovascular, antiviral, antiobesity, muscle relaxant, neuropathic, antibacterial, antidiabetic, central nervous system, antifungal, urology, antispasmodic, pain and inflammation, antihistamine, vitamin, repiratory, antiinflammatory enzyme, respiratory and others. Its products include prescription medicine, over-the-counter drugs and active pharmaceutical ingredients. The company was founded on February 12, 1976 and is headquartered in Hwaseong-si, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 011040 is 6260 KRW — it has increased by 0.16% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange KDPHARM stocks are traded under the ticker 011040.
KDPHARM is going to release the next earnings report on May 13, 2024. Keep track of upcoming events with our Earnings Calendar.
011040 stock is 1.79% volatile and has beta coefficient of 0.24. Check out the list of the most volatile stocks — is KDPHARM there?
Yes, you can track KDPHARM financials in yearly and quarterly reports right on TradingView.
011040 stock has fallen by 0.48% compared to the previous week, the month change is a 3.10% fall, over the last year KDPHARM has showed a 16.20% decrease.
011040 net income for the last quarter is −19.84 B KRW, while the quarter before that showed 541.88 M KRW of net income which accounts for −3.76 K% change. Track more KDPHARM financial stats to get the full picture.
Today KDPHARM has the market capitalization of 169.86 B, it has decreased by 1.72% over the last week.
Like other stocks, 011040 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KDPHARM stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 20, 2024, the company has 405.00 employees. See our rating of the largest employees — is KDPHARM on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So KDPHARM technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating KDPHARM stock shows the sell signal. See more of KDPHARM technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. KDPHARM EBITDA is −19.11 B KRW, and current EBITDA margin is −11.74%. See more stats in KDPHARM financial statements.